Link to this page
National Cancer Institute Thesaurus
Preferred Name | Pegfilgrastim | |
Synonyms |
Filgrastim SD-01 Pegfilgrastim-bmez Pegfilgrastim Biosimilar Nyvepria Pegfilgrastim-cbqv Pegfilgrastim-apgf PF-06881894 SD-01 sustained duration G-CSF Pegfilgrastim-jmdb Pegfilgrastim PEG-filgrastim pegfilgrastim-bmez Pegylated Granulocyte Colony Stimulating Factor pegfilgrastim-apgf filgrastim-SD/01 pegfilgrastim Pegfilgrastim Biosimilar Pegcyte PEGFILGRASTIM pegfilgrastim-cbqv Pegfilgrastim Biosimilar Ziextenzo Pegylated G-CSF Pegfilgrastim Biosimilar PF-06881894 Pegfilgrastim Biosimilar Udenyca Pegfilgrastim Biosimilar HSP-130 Pegylated GCSF Fulphila HSP-130 Jinyouli Neulasta Neulastim Neupopeg Nyvepria Pegcyte SD-01 Udenyca Ziextenzo |
|
Definitions |
A long-acting pegylated form of a recombinant therapeutic agent which is chemically identical to or similar to an endogenous human granulocyte colony-stimulating factor (G-CSF). Produced endogenously by monocytes, fibroblasts, and endothelial cells, G-CSF binds to and activates specific cell surface receptors, stimulating neutrophil progenitor proliferation and differentiation and selected neutrophil functions. Conjugation of the cytokine with a branched polyethylene glycol molecule (pegylation) significantly increases its therapeutic half-life. (NCI04) |
|
ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1854 |
|
Accepted_Therapeutic_Use_For |
Chemotherapy-induced neutropenia
|
|
ALT_DEFINITION |
A drug used to increase numbers of white blood cells in patients who are receiving chemotherapy. It is a type of colony-stimulating factor.
|
|
CAS_Registry |
208265-92-3
|
|
Chemical_Formula |
C3H8NO(C2H4O)n
|
|
code |
C1854
|
|
Concept_In_Subset |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C176424 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C157711 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C186329 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C157712 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116978 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C201600 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116977 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C186341 |
|
Contributing_Source |
CTRP FDA GDC HemOnc PCDC
|
|
DEFINITION |
A long-acting pegylated form of a recombinant therapeutic agent which is chemically identical to or similar to an endogenous human granulocyte colony-stimulating factor (G-CSF). Produced endogenously by monocytes, fibroblasts, and endothelial cells, G-CSF binds to and activates specific cell surface receptors, stimulating neutrophil progenitor proliferation and differentiation and selected neutrophil functions. Conjugation of the cytokine with a branched polyethylene glycol molecule (pegylation) significantly increases its therapeutic half-life. (NCI04)
|
|
Display_Name |
Pegfilgrastim
|
|
FDA_UNII_Code |
3A58010674
|
|
FULL_SYN |
Filgrastim SD-01 Pegfilgrastim-bmez Pegfilgrastim Biosimilar Nyvepria Pegfilgrastim-cbqv Pegfilgrastim-apgf PF-06881894 SD-01 sustained duration G-CSF Pegfilgrastim-jmdb Pegfilgrastim PEG-filgrastim pegfilgrastim-bmez Pegylated Granulocyte Colony Stimulating Factor pegfilgrastim-apgf filgrastim-SD/01 pegfilgrastim Pegfilgrastim Biosimilar Pegcyte PEGFILGRASTIM pegfilgrastim-cbqv Pegfilgrastim Biosimilar Ziextenzo Pegylated G-CSF Pegfilgrastim Biosimilar PF-06881894 Pegfilgrastim Biosimilar Udenyca Pegfilgrastim Biosimilar HSP-130 Pegylated GCSF Fulphila HSP-130 Jinyouli Neulasta Neulastim Neupopeg Nyvepria Pegcyte SD-01 Udenyca Ziextenzo
|
|
Is_Value_For_GDC_Property | ||
label |
Pegfilgrastim
|
|
Legacy Concept Name |
Pegfilgrastim
|
|
Maps_To |
Pegfilgrastim
|
|
NCI_Drug_Dictionary_ID |
37807
|
|
NSC Number |
725961
|
|
PDQ_Closed_Trial_Search_ID |
37807
|
|
PDQ_Open_Trial_Search_ID |
37807
|
|
Preferred_Name |
Pegfilgrastim
|
|
prefixIRI |
Thesaurus:C1854
|
|
Semantic_Type |
Amino Acid, Peptide, or Protein Pharmacologic Substance
|
|
UMLS_CUI |
C1136535
|
|
subClassOf |
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |